These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 15705635

  • 1. Telithromycin activity is reduced by efflux in Streptococcus pyogenes.
    Cantón R, Mazzariol A, Morosini MI, Baquero F, Cornaglia G.
    J Antimicrob Chemother; 2005 Apr; 55(4):489-95. PubMed ID: 15705635
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries.
    Nagai K, Appelbaum PC, Davies TA, Kelly LM, Hoellman DB, Andrasevic AT, Drukalska L, Hryniewicz W, Jacobs MR, Kolman J, Miciuleviciene J, Pana M, Setchanova L, Thege MK, Hupkova H, Trupl J, Urbaskova P.
    Antimicrob Agents Chemother; 2002 Feb; 46(2):546-9. PubMed ID: 11796375
    [Abstract] [Full Text] [Related]

  • 9. Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland: the in vitro activity of telithromcycin versus comparators.
    Shackcloth J, Williams L, Farrell DJ.
    J Infect; 2004 Apr; 48(3):229-35. PubMed ID: 15001301
    [Abstract] [Full Text] [Related]

  • 10. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
    Walsh F, Willcock J, Amyes S.
    J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
    [Abstract] [Full Text] [Related]

  • 11. Increasing telithromycin resistance among Streptococcus pyogenes in Europe.
    Richter SS, Heilmann KP, Dohrn CL, Beekmann SE, Riahi F, Garcia-de-Lomas J, Ferech M, Goossens H, Doern GV.
    J Antimicrob Chemother; 2008 Mar; 61(3):603-11. PubMed ID: 18218647
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
    Tamayo J, Pérez-Trallero E, Gómez-Garcés JL, Alós JI, Spanish Group for the Study of Infection in the Primary Health Care Setting.
    J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.